Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18770533 | MICROORGANISMS AND METHODS FOR THE CONTINUOUS PRODUCTION OF FATTY ACIDS, FATTY ALCOHOLS, AND CULTURED PROTEIN FROM C1 SUBSTRATES | July 2024 | June 2025 | Abandon | 11 | 1 | 1 | No | No |
| 18661739 | METHOD FOR PRODUCING SCLAREOL BY FERMENTATION OF CIGAR TOBACCO FLOWER BUDS | May 2024 | October 2024 | Allow | 5 | 1 | 0 | No | No |
| 18635214 | SERINE PROTEASES | April 2024 | May 2025 | Allow | 13 | 0 | 0 | No | No |
| 18627748 | METHOD FOR EXTRACTING PULLULAN POLYSACCHARIDE FROM HIGH-VISCOSITY FERMENTATION BROTH | April 2024 | August 2024 | Allow | 5 | 1 | 0 | No | No |
| 18623612 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | April 2024 | April 2025 | Allow | 13 | 0 | 1 | Yes | No |
| 18614099 | KETOREDUCTASE POLYPEPTIDES FOR THE PRODUCTION OF (R)-3-HYDROXYTHIOLANE | March 2024 | April 2025 | Allow | 12 | 1 | 0 | Yes | No |
| 18437445 | GLUCOAMYLASE ENGINEERED YEAST AND FERMENTATION METHODS | February 2024 | April 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18435340 | METHODS FOR MAKING L-GLUFOSINATE | February 2024 | March 2025 | Allow | 14 | 1 | 0 | No | No |
| 18435544 | METHODS FOR MAKING L-GLUFOSINATE | February 2024 | April 2025 | Allow | 14 | 1 | 0 | No | No |
| 18412090 | INSECT INHIBITORY TOXIN FAMILY ACTIVE AGAINST HEMIPTERAN AND/OR LEPIDOPTERAN INSECTS | January 2024 | March 2025 | Abandon | 14 | 1 | 1 | No | No |
| 18402680 | ENGINEERED NUCLEIC ACID-GUIDED NUCLEASES | January 2024 | July 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18525234 | UDP-DEPENDENT GLYCOSYLTRANSFERASE FOR HIGH EFFICIENCY PRODUCTION OF REBAUDIOSIDES | November 2023 | April 2025 | Allow | 16 | 1 | 0 | No | No |
| 18511394 | METHODS OF PRODUCING MORPHINAN ALKALOIDS AND DERIVATIVES | November 2023 | June 2025 | Allow | 19 | 1 | 0 | No | No |
| 18506648 | Liquid Cleaning Compositions Comprising Protease Variants | November 2023 | December 2024 | Allow | 14 | 1 | 0 | No | No |
| 18504743 | Liquid Cleaning Compositions Comprising Protease Variants | November 2023 | December 2024 | Allow | 13 | 2 | 0 | Yes | No |
| 18496269 | AUTOMATIC DISHWASHING DETERGENT COMPOSITIONS | October 2023 | February 2025 | Abandon | 16 | 0 | 1 | No | No |
| 18384044 | PRODUCTION OF CAROTENOIDS AND APOCAROTENOIDS | October 2023 | April 2025 | Allow | 17 | 2 | 1 | Yes | No |
| 18485895 | TUNABLE NANOSCALE CAGES FROM SELF-ASSEMBLING DNA AND PROTEIN BUILDING BLOCKS | October 2023 | March 2025 | Allow | 17 | 1 | 0 | Yes | No |
| 18485501 | Construction Method and Application of Microorganism Capable of Realizing High Production of Lacto-N-tetrose | October 2023 | April 2024 | Allow | 6 | 1 | 0 | No | No |
| 18453987 | METHODS AND ORGANISMS WITH INCREASED CARBON FLUX EFFICIENCIES | August 2023 | June 2025 | Allow | 22 | 2 | 1 | No | No |
| 18227147 | HETEROLOGOUS PRODUCTION OF 10-METHYLSTEARIC ACID | July 2023 | December 2024 | Abandon | 16 | 1 | 0 | No | No |
| 18352899 | KETOREDUCTASE POLYPEPTIDES AND POLYNUCLEOTIDES | July 2023 | November 2024 | Allow | 16 | 1 | 1 | No | No |
| 18339027 | MICROORGANISMS AND METHODS FOR THE CONTINUOUS CO-PRODUCTION OF HIGH-VALUE, SPECIALIZED PROTEINS AND CHEMICAL PRODUCTS FROM C1-SUBSTRATES | June 2023 | October 2024 | Allow | 16 | 2 | 1 | Yes | No |
| 18338242 | RECOMBINANT OLIVETOLIC ACID CYCLASE POLYPEPTIDES ENGINEERED FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS | June 2023 | April 2024 | Allow | 10 | 1 | 0 | Yes | No |
| 18333776 | COMPOSITIONS FOR SACCHARIFICATION OF CELLULOSIC MATERIAL | June 2023 | September 2024 | Allow | 15 | 1 | 0 | No | No |
| 18208030 | PRODUCTION OF ISOPRENOIDS | June 2023 | July 2024 | Allow | 13 | 1 | 0 | No | No |
| 18327373 | A UNIVERSAL PLATFORM TO ENHANCE CRISPR-BASED GENE EDITING FOR IN VIVO THERAPIES | June 2023 | April 2024 | Allow | 11 | 0 | 1 | No | No |
| 18199278 | METHODS FOR GENOMIC INTEGRATION FOR KLUYVEROMYCES HOST CELLS | May 2023 | August 2024 | Allow | 15 | 1 | 0 | No | No |
| 18197870 | COMPOSITIONS AND METHODS INVOLVING ENGINEERED P27 | May 2023 | January 2025 | Allow | 20 | 2 | 1 | Yes | No |
| 18304187 | Inducible, Tunable, and Multiplex Human Gene Regulation Using CRISPR-Cpf1 | April 2023 | September 2024 | Allow | 17 | 2 | 0 | No | No |
| 18301460 | PROTEASE VARIANTS AND USES THEREOF | April 2023 | July 2024 | Allow | 15 | 1 | 0 | Yes | No |
| 18179136 | METHODS FOR MAKING L-GLUFOSINATE | March 2023 | October 2023 | Allow | 7 | 1 | 0 | No | No |
| 18040629 | PRODUCTION OF A MIXTURE OF NEUTRAL NON-FUCOSYLATED OLIGOSACCHARIDES BY A CELL | February 2023 | February 2024 | Allow | 13 | 1 | 1 | Yes | No |
| 18161236 | BIOSYNTHESIS OF RETINOIDS | January 2023 | November 2024 | Allow | 22 | 1 | 1 | No | No |
| 18062628 | BIOSYNTHETIC PRODUCTION OF GAMMA-LACTONES | December 2022 | April 2025 | Allow | 28 | 1 | 1 | Yes | No |
| 18062198 | Integration Sites in CHO Cells | December 2022 | February 2024 | Allow | 14 | 0 | 0 | No | No |
| 18055713 | LIPID-ENCAPSULATED DUAL-CLEAVING ENDONUCLEASE FOR DNA AND GENE EDITING | November 2022 | August 2023 | Allow | 9 | 1 | 0 | Yes | No |
| 17986618 | LACTASE ENZYMES WITH IMPROVED PROPERTIES | November 2022 | October 2024 | Allow | 23 | 1 | 1 | No | No |
| 17983665 | PROBIOTIC BACTERIA FOR YEAST BIOETHANOL PRODUCTION | November 2022 | June 2024 | Allow | 19 | 1 | 0 | Yes | No |
| 18052066 | Biocementation Method and System | November 2022 | August 2024 | Allow | 21 | 1 | 0 | Yes | No |
| 18050245 | VARIANT AIM | October 2022 | August 2024 | Abandon | 22 | 1 | 0 | Yes | No |
| 17969715 | AFFINITY TAG FOR RECOMBINATION PROTEIN RECRUITMENT | October 2022 | August 2024 | Abandon | 22 | 0 | 1 | No | No |
| 17957218 | AprL-CLADE PROTEASE VARIANTS AND USES THEREOF | September 2022 | February 2025 | Allow | 29 | 1 | 0 | Yes | No |
| 17934560 | PRENYLTRANSFERASE VARIANTS WITH INCREASED THERMOSTABILITY | September 2022 | May 2024 | Allow | 19 | 1 | 0 | No | No |
| 17900590 | ENZYMES AND APPLICATIONS THEREOF | August 2022 | April 2024 | Allow | 19 | 1 | 0 | No | No |
| 17799414 | PREPARING AND MODIFYING MEROTERPENE POLYKETIDES, KETONES, AND LACTONES FOR CANNABINOID SEMISYNTHESIS | August 2022 | June 2025 | Abandon | 34 | 0 | 1 | No | No |
| 17882680 | IMMOBILIZED ENZYME PRODUCTION LINE, METHOD OF MAKING AN IMMOBILIZED ENZYME PRODUCTION LINE, AND METHOD OF MAKING COMPOUNDS USING THE IMMOBILIZED ENZYME PRODUCTION LINE | August 2022 | August 2024 | Abandon | 24 | 1 | 1 | No | No |
| 17816892 | METHODS OF REDUCING ODOR | August 2022 | July 2023 | Allow | 11 | 2 | 1 | Yes | No |
| 17816630 | HETEROLOGOUS BIOSYNTHESIS OF NODULISPORIC ACID | August 2022 | April 2024 | Allow | 20 | 0 | 1 | Yes | No |
| 17759537 | Polypeptide Variants | July 2022 | March 2025 | Allow | 32 | 0 | 1 | Yes | No |
| 17871400 | METHOD FOR PRODUCING MERCAPTANS BY DISULFIDE ENZYME HYDROGENOLYSIS | July 2022 | July 2024 | Abandon | 23 | 1 | 0 | No | No |
| 17813950 | KETOREDUCTASE POLYPEPTIDES FOR THE PRODUCTION OF (R)-3-HYDROXYTHIOLANE | July 2022 | December 2023 | Allow | 17 | 1 | 0 | No | No |
| 17791412 | METHOD FOR PRODUCING BRANCHED DEXTRIN WITH IMPROVED WHITE TURBIDITY | July 2022 | April 2025 | Allow | 34 | 1 | 0 | No | No |
| 17854774 | Enzyme Variants and Polynucleotides Encoding The Same | June 2022 | August 2023 | Allow | 14 | 1 | 1 | No | No |
| 17852246 | COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA | June 2022 | June 2024 | Abandon | 23 | 1 | 0 | No | No |
| 17849571 | MEDIUM COMPOSITION FOR PRODUCING ALCOHOL FROM SYNTHETIC GAS COMPRISING ETHANOL AND METHOD FOR PRODUCING ALCOHOL USING THE SAME | June 2022 | December 2023 | Allow | 17 | 1 | 0 | No | No |
| 17846771 | LIPID-ENCAPSULATED DUAL-CLEAVING ENDONUCLEASE FOR DNA AND GENE EDITING | June 2022 | March 2025 | Allow | 33 | 2 | 0 | No | No |
| 17846935 | METHODS OF PRODUCING NOR-OPIOID AND NAL-OPIOID BENZYLISOQUINOLINE ALKALOIDS | June 2022 | August 2024 | Allow | 26 | 1 | 1 | Yes | No |
| 17845842 | Yeast Cells and Methods for Producing Fatty Alcohols | June 2022 | August 2024 | Allow | 26 | 2 | 0 | No | No |
| 17829416 | POLYPEPTIDE FOR HYDROLYTIC CLEAVAGE OF ZEARALENONE AND/OR ZEARALENONE DERIVATIVES, ISOLATED POLYNUCLEOTIDE THEREOF AS WELL AS A POLYPEPTIDE CONTAINING AN ADDITIVE, USE OF SAME AS WELL AS A PROCESS | June 2022 | April 2024 | Allow | 22 | 2 | 0 | Yes | No |
| 17829431 | POLYPEPTIDE FOR HYDROLYTIC CLEAVAGE OF ZEARALENONE AND/OR ZEARALENONE DERIVATIVES, ISOLATED POLYNUCLEOTIDE THEREOF AS WELL AS A POLYPEPTIDE CONTAINING AN ADDITIVE, USE OF SAME AS WELL AS A PROCESS | June 2022 | February 2024 | Allow | 20 | 1 | 0 | No | No |
| 17828457 | CLASS OF SUCROSE ESTERS AND A METHOD FOR THEIR PREPARATION | May 2022 | January 2024 | Allow | 20 | 1 | 0 | No | No |
| 17824118 | PRENYLTRANSFERASE VARIANTS WITH INCREASED THERMOSTABILITY | May 2022 | August 2022 | Allow | 3 | 0 | 0 | Yes | No |
| 17804052 | ENHANCING PRODUCT STREAMS FROM ETHANOL PRODUCTION | May 2022 | September 2024 | Allow | 28 | 3 | 0 | Yes | No |
| 17779967 | METHOD FOR ENZYMATICALLY PRODUCING MAYTANSINOL | May 2022 | June 2025 | Allow | 37 | 2 | 1 | Yes | No |
| 17756400 | METHODS AND COMPOSITIONS FOR PRODUCING ETHYLENE FROM RECOMBINANT MICROORGANISMS | May 2022 | May 2025 | Abandon | 35 | 0 | 1 | No | No |
| 17778712 | CARBONYL REDUCTASE, NUCLEIC ACID ENCODING SAME, AND METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND USING SAME | May 2022 | July 2025 | Allow | 37 | 1 | 1 | Yes | No |
| 17750037 | METHOD FOR PRODUCING JASMONIC ACID BY SOLID STATE FERMENTATION OF MICROORGANISMS | May 2022 | May 2025 | Abandon | 36 | 1 | 0 | No | No |
| 17778018 | USE OF CITRONELLOL IN PREPARING PREPARATION FOR PROMOTING EXPRESSION OF VIRULENCE GENE TOXA OF PSEUDOMONAS AERUGINOSA | May 2022 | September 2023 | Allow | 16 | 2 | 0 | Yes | No |
| 17745997 | ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | May 2022 | February 2024 | Allow | 21 | 2 | 0 | Yes | No |
| 17746952 | BACTERIAL TOXINS AND USES THEREOF AS RAS SPECIFIC PROTEASES FOR TREATING CELL PROLIFERATION DISEASES AND DISORDERS | May 2022 | April 2025 | Allow | 35 | 1 | 1 | Yes | No |
| 17744773 | NOVEL PROTEASES AND USES THEREOF | May 2022 | May 2025 | Abandon | 36 | 0 | 1 | No | No |
| 17776686 | SQUALENE HOPENE CYCLASE (SHC) VARIANTS | May 2022 | March 2025 | Allow | 34 | 1 | 1 | Yes | No |
| 17741763 | SACCHARIFICATION REACTION MIXTURE, SACCHARIFICATION ENZYME COMPOSITION, SUGAR PRODUCTION METHOD, AND ETHANOL PRODUCTION METHOD | May 2022 | February 2024 | Allow | 21 | 1 | 1 | Yes | No |
| 17735222 | POLYPEPTIDE VARIANTS | May 2022 | June 2024 | Allow | 26 | 2 | 1 | No | No |
| 17734432 | MYELOID DIFFERENTIATION FACTOR 2 (MD2) SIGNALING AND MODULATION | May 2022 | March 2024 | Allow | 23 | 2 | 0 | No | No |
| 17732799 | Microbial Production Of Fatty Diols | April 2022 | October 2024 | Abandon | 29 | 1 | 1 | No | No |
| 17769655 | ARTIFICIALLY SYNTHESIZED mRNA AND USE OF SAME | April 2022 | May 2025 | Allow | 37 | 2 | 1 | Yes | No |
| 17716348 | STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF | April 2022 | April 2025 | Allow | 36 | 2 | 0 | No | Yes |
| 17713891 | OPTIMIZATION OF ENZYME REPLACEMENT THERAPY FOR TREATMENT OF HOMOCYSTINURIA | April 2022 | March 2024 | Allow | 23 | 2 | 0 | No | No |
| 17657241 | GLUCOAMYLASE ENGINEERED YEAST AND FERMENTATION METHODS | March 2022 | November 2023 | Allow | 20 | 2 | 0 | Yes | No |
| 17707030 | PROCESS FOR TREATING LIGNOCELLULOSIC BIOMASS | March 2022 | February 2025 | Allow | 35 | 4 | 1 | No | No |
| 17691912 | Process For Second Generation Lactic Acid Production | March 2022 | June 2024 | Allow | 27 | 2 | 0 | Yes | No |
| 17641740 | GLUCOCEREBROSIDASE MUTANTS | March 2022 | February 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17677926 | THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME | February 2022 | March 2024 | Abandon | 25 | 1 | 1 | No | No |
| 17634342 | NOVEL OLEATE HYDRATASES | February 2022 | February 2025 | Abandon | 36 | 0 | 1 | No | No |
| 17589198 | Method for fermenting biomass and producing material sheets and suspensions thereof | January 2022 | February 2025 | Abandon | 36 | 1 | 0 | No | No |
| 17631066 | A Recombinant of Hydrogenophilus Bacterium Producing Lactic Acid | January 2022 | February 2025 | Allow | 37 | 1 | 1 | Yes | No |
| 17570312 | Compositions and Methods for Dust Control | January 2022 | July 2024 | Allow | 31 | 2 | 0 | Yes | No |
| 17568547 | INSECT INHIBITORY TOXIN FAMILY ACTIVE AGAINST HEMIPTERAN AND/OR LEPIDOPTERAN INSECTS | January 2022 | October 2023 | Allow | 21 | 2 | 1 | No | No |
| 17621982 | MODIFIED YEAST AND METHOD FOR INCREASING LYSINE CONTENT IN FERMENTATION CO-PRODUCTS | December 2021 | December 2024 | Allow | 36 | 1 | 1 | No | No |
| 17622112 | PEGYLATED CYSTATHIONINE BETA SYNTHASE FOR ENZYME THERAPY FOR TREATMENT OF HOMOCYSTINURIA | December 2021 | March 2025 | Allow | 39 | 1 | 0 | No | No |
| 17555731 | POLYPEPTIDE FOR HYDROLYTIC CLEAVAGE OF ZEARALENONE AND/OR ZEARALENONE DERIVATIVES, ISOLATED POLYNUCLEOTIDE THEREOF AS WELL AS A POLYPEPTIDE CONTAINING AN ADDITIVE, USE OF SAME AS WELL AS A PROCESS | December 2021 | October 2023 | Allow | 22 | 1 | 1 | No | No |
| 17554537 | CELL-FREE PRODUCTION OF GERANYL PYROPHOSPHATE FROM GLYCEROL IN A CELL-FREE MANUFACTURING SYSTEM | December 2021 | January 2024 | Allow | 25 | 1 | 1 | Yes | No |
| 17554278 | DEHYDRATASE VARIANTS WITH IMPROVED SPECIFIC ACTIVITY FOR THE PRODUCTION OF PYRUVATE FROM GLYCERATE | December 2021 | October 2023 | Allow | 22 | 2 | 0 | Yes | No |
| 17553279 | USE OF ETHANOLOGENS IN BIOFUEL PRODUCTION | December 2021 | July 2024 | Allow | 31 | 3 | 0 | No | No |
| 17548208 | RECOMBINANT ACYL ACTIVATING ENZYME (AAE) GENES FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | December 2021 | May 2024 | Abandon | 29 | 2 | 1 | No | No |
| 17536919 | NON-CALORIC SWEETENERS AND METHODS FOR SYNTHESIZING | November 2021 | September 2023 | Allow | 21 | 0 | 1 | Yes | No |
| 17530018 | METHODS FOR MAKING L-GLUFOSINATE | November 2021 | October 2023 | Allow | 23 | 1 | 0 | No | No |
| 17454339 | SYNTHETIC PROMOTER BASED ON GENE FROM ACID-RESISTANT YEAST | November 2021 | June 2023 | Allow | 19 | 1 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner RAGHU, GANAPATHIRAM.
With a 33.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 18.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner RAGHU, GANAPATHIRAM works in Art Unit 1652 and has examined 1,408 patent applications in our dataset. With an allowance rate of 72.1%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 26 months.
Examiner RAGHU, GANAPATHIRAM's allowance rate of 72.1% places them in the 27% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by RAGHU, GANAPATHIRAM receive 1.64 office actions before reaching final disposition. This places the examiner in the 45% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by RAGHU, GANAPATHIRAM is 26 months. This places the examiner in the 60% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +30.1% benefit to allowance rate for applications examined by RAGHU, GANAPATHIRAM. This interview benefit is in the 81% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 32.2% of applications are subsequently allowed. This success rate is in the 60% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 59.1% of cases where such amendments are filed. This entry rate is in the 81% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 90.9% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 66% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 81.6% of appeals filed. This is in the 71% percentile among all examiners. Of these withdrawals, 80.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 69.8% are granted (fully or in part). This grant rate is in the 87% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 8.3% of allowed cases (in the 94% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.